Boston Scientific names global chief medical officer
Courtesy Monash University
Ian Meredith currently serves as professor of medicine and cardiology for Monash University.
Ian Meredith will join Boston Scientific as executive vice president and global chief medical officer beginning in January, the company announced Monday.
Meredith is one of the world’s leading cardiac device clinical investigators, according to Boston Scientific CEO Mike Mahoney, with his relationships and experience pushing novel technologies forward set to be a boon for the company.
According to Boston Scientific, Meridith has performed more than 10,000 invasive cardiac and coronary procedures, published more than 300 manuscripts and has been chief or principal investigator on 30 major international multi-center trials, including first-in-man trials of new drug-eluting stents. He currently serves as professor of medicine and cardiology for Monash University, director of MonashHeart and Monash Health and as executive director of the Monash Cardiovascular Research Centre in Melbourne, Australia.
Meredith succeeds Executive Vice President and Global Chief Medical Officer Keith Dawkins, M.D., who will retire from the company in January.
WBJ Web Partners
Most Recent
Most Recent
0 Comments